XORTX Announces Appointment of Chief Technology Officer

20.01.2022 - CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) - XORTX Therapeutics Inc. ('XORTX' or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical therapeutics company focused on developing innovative therapies to treat ...

Related Keywords

Nick Rigopulos ,Allen Davidoff ,University Of Alberta ,Therapeutics Inc ,Methylation Sciences Inc ,Active Pass ,Autosomal Dominant Polycystic Kidney Disease ,